-
-
-
-
-
-
-
Emergent BioSolutions partners with Substipharm for JE vaccine manufacturing
-
-
-
-
-
-
-
Emergent BioSolutions (EBS) Misses Q4 EPS by 81c
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Emergent BioSolutions (EBS)
-
-
-
-
-
-
-
Emergent BioSolutions (EBS) Tops Q2 EPS by 26c
-
-
-
-
-
-
-
Emergent BioSolutions (EBS) Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International
-
-
-
-
-
-
-
Emergent BioSolutions (EBS) Gains Exclusive Commercial Rights to KLOXXADO Nasal Spray from Hikma Pharmaceuticals
-
-
-
-
-
-
-
Emergent BioSolutions (EBS) Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa
-
412,707 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

